Team:Freiburg bioware/Project/FOS

From 2009.igem.org

(Difference between revisions)
(New page: <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" dir="ltr" lang="en-US"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /> <meta http-equiv="X-UA-C...)
 
(27 intermediate revisions not shown)
Line 1: Line 1:
-
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"
+
<html xmlns="http://www.w3.org/1999/xhtml" dir="ltr"
-
  dir="ltr" lang="en-US">
+
  lang="en-US">
<head>
<head>
-
   <meta http-equiv="Content-Type"
+
   <meta content="text/html; charset=UTF-8"
-
content="text/html; charset=UTF-8" />
+
http-equiv="Content-Type" />
-
   <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" />
+
   <meta content="IE=EmulateIE7" http-equiv="X-UA-Compatible" />
   <title>FREiGEM</title>
   <title>FREiGEM</title>
-
   <script type="text/javascript" src="script.js"></script>
+
   <script src="script.js" type="text/javascript"></script>
-
   <link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css"
+
   <link media="screen" type="text/css" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css"
-
  type="text/css" media="screen" />
+
  rel="stylesheet" />
-
<!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css_ie7&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]-->
+
<!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style_ie7.css&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]-->
</head>
</head>
<body>
<body>
Line 32: Line 32:
<div class="r"></div>
<div class="r"></div>
<ul class="art-menu">
<ul class="art-menu">
-
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware"
+
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware"><span
-
class="active"><span class="l"></span><span
+
class="l"></span><span class="r"></span><span
-
class="r"></span><span class="t">Home</span></a></li>
+
class="t">Home</span></a></li>
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
Line 45: Line 45:
     </ul>
     </ul>
   </li>
   </li>
-
   <li><a
+
   <li><a class="active"
  href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span
  href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
Line 54: Line 54:
  href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a>
  href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a>
       </li>
       </li>
-
      <li><a
+
   
-
href="https://2009.igem.org/Team:Freiburg_bioware/Project#Subprojects">Subprojects</a></li>
+
       <li><a
       <li><a
  href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li>
  href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li>
Line 73: Line 72:
     </ul>
     </ul>
   </li>
   </li>
-
   <li><a
+
   <li><a href="#"><span class="l"></span><span
-
href="https://2009.igem.org/Team:Freiburg_bioware/Notebook"><span
+
class="r"></span><span class="t">Notebook</span></a></li>
-
class="l"></span><span class="r"></span><span
+
-
class="t">Notebook</span></a></li>
+
   <li><a
   <li><a
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><span
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><span
Line 97: Line 94:
  href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span
  href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
-
  class="t">Modeling</span></a></li>
+
  class="t">Modeling</span></a> </li>
</ul>
</ul>
</div>
</div>
Line 124: Line 121:
<div style="text-align: center;"></div>
<div style="text-align: center;"></div>
<div style="text-align: left;">
<div style="text-align: left;">
-
<div class="thumb tnone">
+
 
-
<div class="thumbinner" style="width: 252px;"><span
+
 
-
class="image"></span>
+
 
-
<div class="thumbcaption">
+
<table
-
<table style="text-align: left; width: 260px; height: 286px;"
+
style="float: left; text-align: left; margin-top: 2px; margin-right: 20px; margin-bottom: 15px; background-color: rgb(205, 219, 229); width: 263px; height: 237px;"
-
  border="0" cellpadding="2" cellspacing="2">
+
  border="1" cellpadding="2" cellspacing="0">
-
   <tbody>
+
   <tbody bgcolor="#e2eff9">
     <tr>
     <tr>
-
       <td><span class="image"><img
+
       <td><img style="width: 250px; height: 240px;"
-
style="border: 0px solid ; width: 250px; height: 250px;"
+
  alt=""
-
  alt="two human c-Fos:c-Jun:DNA complexes"
+
  src="https://static.igem.org/mediawiki/2009/5/57/Freiburg09_1FOS.jpg" /></td>
-
  src="https://static.igem.org/mediawiki/2009/5/57/Freiburg09_1FOS.jpg"
+
-
class="thumbimage" /></span></td>
+
     </tr>
     </tr>
     <tr>
     <tr>
-
       <td>two human c-Fos:c-Jun:DNA complexes</td>
+
       <td><small>Figure1: Human c-Fos:c-Jun:DNA complexes</small></td>
     </tr>
     </tr>
   </tbody>
   </tbody>
</table>
</table>
 +
</div>
</div>
</div>
</div>
</div>
</div>
<p><b>Introduction</b><br />
<p><b>Introduction</b><br />
-
We also thought of an alternative way of binding of the heterodimeric
+
We also thought of an alternative way of binding of the heterodimeric Fok to the DNA avoiding the necessity of labeled oligos and their binding proteins. Therefore, we used the DNA binding domain of a transcription factor as a new adapter between the Fok construts and the DNA. We focused on the binding domain of the Activator Protein-1 (AP-1), a crucial transcription factor implicated in numerous cancers. <br><br>
-
Fok to the DNA avoiding the necessity of labelled oligos and their
+
AP-1, which belongs to the bZIP type of transcription factors, binds DNA as a dimer like many eukaryotic transcription factor. Protein-protein interaction is mediated via a leucin zipper (ZIP), and with their basic region (b) they bind DNA. Nine homologues of the AP-1 leucine zipper region have been characterized, among them natural occurring c-Fos, c-Jun and library-designed winning peptides FosW and JunW. Each of the homologues is able to form heterodimers, some also form homodimers.  <br><br>
-
binding proteins using the binding domain of a transcription factor as
+
 
-
a new adapter. We focused on the binding domain of the activator
+
 
-
protein-1 (AP-1) a crucial transcription factor implicated in numerous
+
There are two classes of core DNA sequences, the sequences TRE (TGACTCA) and CRE (TGACGTCA), which are recognized by the different AP-1 factors.  <br><br>
-
cancers. The protein is composed by a series of dimers. Nine homologues
+
For our needs, we chose the natural bZIP sequence of Fos and Jun as well as the library-selected FosW sequence. By fusion of Fos with Splitli-Fok_a, the construct Fos-Splitli-Fok_a was obtained. Control of DNA cleavage occurs on two levels: (i) using the bZIP sequence of Jun as adapter, DNA binding can be induced, and (ii) adding Fok_i will render Fok activ leading to DNA cleavage.    <br><br>
-
of the AP-1 leucine zipper region have been characterized, among them
+
For further control of DNA cleavage activity, a light-switchable peptide, FosW, can be used to interfere with Fos/Jun DNA binding. For this, two Cys residues were introdued in FosW presenting reactive sites for thiol-reactive linkers.  Thus an azobenzene derivative as intramolecular cross-linker can be coupled to the cysteines. Depending on the wavelenth of light used the linker undergoes cis/trans isomerization promoting the folding or unfolding of the FosW helix (see Figure 3). <br>
-
c-Fos, c-Jun and semirational library-designed winning peptides FosW
+
<p style="text-align: center">
-
and JunW. Via leucin zipper they interact among each other and with
+
<table style="text-align: center; width: 412px; height: 303px;"
-
their basic region they bind DNA. </p>
+
border="0" cellpadding="2" cellspacing="2">
 +
  <tbody>
 +
    <tr>
 +
      <td><a
 +
href="http://www.molbiotech.uni-freiburg.de/iGEM/wiki2009/index.php/Image:Freiburg09_021009-HisFluASplitFoki_%2B_%C3%9Flac-his_highres%2Bbearbeitet.jpg"
 +
class="image"
 +
title="Western Blot: His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls"><img
 +
alt="Western Blot: His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls"
 +
src="https://static.igem.org/mediawiki/2009/9/9c/Freiburg09_Photo-control_fos.jpg"
 +
class="thumbimage" border="0" height="222"
 +
width="666" /></a></td>
 +
    </tr>
 +
    <tr>
 +
      <td>Figure 3: light-switchable FosW interrupts binding of Jun:Fos</td>
 +
    </tr>
 +
  </tbody>
 +
</table></p><br><br>
 +
Using this light-switchable FosW derivative, FosW binds in its light-activated form to Jun and Fos, displacing them from the DNA and thus disrupts Fok-mediated DNA cleavage. Switching FosW back to its inactivated form, Jun and Fos are released, can rebind to the DNA and Fok-mediated cleavage should occur again. <br><br>
 +
The assay with the photoswitchable FosWinner interrupting the binding of the heterodimeric complex of Fos and Jun was already done by the laboratory of Katja Arndt in Freiburg and underlines the feasibility of the method.<br>
 +
 
<p><b>Methods</b><br />
<p><b>Methods</b><br />
-
Now we ordered plasmids encoding the sequences for the bZip domains of
+
 
-
c-Fos linked to a His-tag for the purification which could then be
+
<table
-
linked to Fok_a and expressed as soluble proteins in Escherichia coli.
+
style="margin-top: 4px; margin-left: 20px; text-align: left; float: right; background-color: rgb(205, 219, 229); width: 343px; height: 317px;"
-
First we fused Splitli-Fok_a with Fos and will express this hybrid
+
border="1" cellpadding="2" cellspacing="0">
-
protein simultanously with GST-FosW. The His_Fos-Splitli-Fok_a,
+
  <tbody bgcolor="#e2eff9">
-
GST-FosW and His-FluA-Splitli-Fok_i constructs were cloned into our
+
    <tr>
-
expression vector pEx under use of the iGEM compatible restriction
+
      <td><img style="width: 500px;" alt=""
-
sites under the lac control system to avoid any deleterious effect to
+
src="https://static.igem.org/mediawiki/2009/e/e1/Freiburg09_Fos.fosw.scheme.png" /><br />
-
the cell with an ampicillin resictance. RV308 and BL21de3 served as the
+
      </td>
-
host for the experiments. After induction of the recombinant cells with
+
    </tr>
-
0.6-0.7 mM isopropyl-beta-D-thiogalactopyranoside (IPTG), the hybrid
+
    <tr>
-
proteins will be purified to homogeneity by a gluthation column binding
+
      <td><small>Figure 2: Above: Fos and Jun dimerize, bind the DNA and lead Fok construct to DNA, Below: activated FosW prevents DNA binding</small></td>
-
FosW, followed by the purification of Fos-SplitLi-Foka through binding
+
    </tr>
-
at FosW. The GST column was loaded with glutathione. </p>
+
  </tbody>
-
<p>For an analysis of the cleavage activity of the
+
</table>
-
Fos-Splitli_Fok_a construct together with FosW we will use reporter
+
 
-
plasmids containing the target recognition sequences of Fos and FosW as
+
We ordered the sequences for the basic leucine zipper (bZip) domains of c-Fos linked to a His-tag for the purification. The cloning of the construct His_Fos and Splitli-Foka into the pEX expression vector was done by a triple ligation. The first insert, His_Fos was cut out by XbaI and AgeI, the second insert, Splitli-Fok_a by NgoMIV and PstI, the vector was cut open with XbaI and PstI. Now the whole construct His_Fos-Splitli-Fok_a can be expressed as a soluble protein in E. coli. For further or alternative purification in addition to His-tag/Ni-NTA purification, we used a GST-FosW fusion protein from the stock of the laboratory of Katja Arndt, where GST (glutathione S-transferase) can bind to GSH (glutathion) sepharose. GST-FosW was expressed in E. coli and bound to the GSH-Sepharose column. This can serve as affinity column for the purification of His_Fos-Splitli-Fok_a. The already expressed His-FluA-Splitli-Fok_i is serving as an expressed Fok_i protein, but any other Fok_i should work as well.
-
substrates. There are two classes of core sequences, the sequences TRE
+
For the recombinant expression, RV308 served as host for His_Fos-Splitli-Fok_a and BL21de3 for His-FluA-Splitli-Fok_i. For induction of expression, we used 0.6 mM isopropyl-beta-D-thiogalactopyranoside (IPTG). His-FluA-Splitli-Fok_i was purified to homogeneity via a Ni-NTA column, whereas His_Fos-Splitli-Fok_a will be purified by an affinity chromatography using a glutathion column with bound GST-FosW.  
-
(TGACTCA) and CRE (TGACGTCA), which were recognized by the different
+
For analysis of the cleavage activity of the Fos-Splitli_Fok_a construct interacting with Jun and His-FluA-Splitli-Fok_i we will use reporter plasmids containing the target recognition sequences of Fos and Jun as substrates.  
-
AP-1 factors. In a mixture of the expressed protein Fos-Splitli-Fok_a
+
<br />
-
with GST-FosW, His-FluA-Splitli-Fok_i serving as an expressed Fok_i
+
-
protein and the target DNA, Fos should dimerize with FosW. After
+
-
activation of the Fok_i and Fok_a partners, the DNA should be cut.<br />
+
</p>
</p>
<p><b>Results and Discussion</b><br />
<p><b>Results and Discussion</b><br />
-
The cloning of the construct His_Fos and Splitli-Foka into the pEX
+
The cloning of the construct His_Fos and Splitli-Foka into the pEX expression vector was done by a triple ligation. The first insert, His_Fos was cut out by XbaI and AgeI, the second insert, Splitli-Fok_a by NgoMIV and PstI, the vector was cut open with XbaI and PstI. The cloning was successful, and the concentration of the plasmid and the sequencing of clones were good.  
-
expression vector was done by a triple ligation. The first insert,
+
-
His_Fos was cut out by XbaI and AgeI, the second insert, Splitli-Fok_a
+
-
by NgoMIV and PstI, the vector was cut open with XbaI and PstI. The
+
-
cloning was successful and the concentration of the plasmid and the
+
-
sequencing of clones were good.
+
</p>
</p>
<table id="table_1" border="1" cellpadding="4"
<table id="table_1" border="1" cellpadding="4"
Line 240: Line 247:
   </tbody>
   </tbody>
</table>
</table>
-
<p>The expression of the single parts Fos-Splitli-Fok_a, GST-FosW
+
<p>The recombinant expression of the single parts His_Fos-Splitli-Fok_a, GST-FosW and His-FluA-Splitli-Fok_i was performed. His-FluA-Splitli-Fok_i was successfully purified via a Ni-NTA column. The western blot with an anti-His antibody shows a band of the expected size of 467 kDa in the pooled elution fraction. GST-FosW was expressed and coupled to the GSH-sepharose column for the purification of His_Fos-Splitli-Fok_a, which will be the next step followed by the in vitro cleavage assays.  
-
and
+
-
His-FluA-Splitli-Fok_i was done. His-FluA-Splitli-Fok_i was also
+
-
successfully purified via a Ni-NTA column. The western blot shows bands
+
-
of the expected size of 46,7kDa in the pooled elution fraction.
+
-
Purification and in vitro cutting assays will follow.
+
</p>
</p>
-
<div class="thumb tnone">
+
<table width="400">
-
<div class="thumbinner" style="width: 402px;">
+
-
<div class="thumbcaption">
+
-
<div class="magnify"><a
+
-
href="http://www.molbiotech.uni-freiburg.de/iGEM/wiki2009/index.php/Image:Freiburg09_021009-HisFluASplitFoki_%2B_%C3%9Flac-his_highres%2Bbearbeitet.jpg"
+
-
class="internal" title="Enlarge"><br />
+
-
</a></div>
+
-
<br />
+
-
<table style="text-align: left; width: 412px; height: 303px;"
+
-
border="0" cellpadding="2" cellspacing="2">
+
-
  <tbody>
+
     <tr>
     <tr>
       <td><a
       <td><a
Line 269: Line 261:
     </tr>
     </tr>
     <tr>
     <tr>
-
       <td>Western
+
       <td>Figure 5: Western Blot (anti-His antibody): His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls for His-tag detection.</td>
-
Blot: His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad
+
-
range, pool of elution fractions 2-5, empty lane, 3 positive controls</td>
+
     </tr>
     </tr>
   </tbody>
   </tbody>
Line 278: Line 268:
</div>
</div>
</div>
</div>
-
<p>As a prospect the additional feature of photo-switchability of
+
<p><br />
-
Fos
+
-
can be generated, allowing regulation of the enzyme&rsquo;s
+
-
activity.
+
-
Introduction of cysteine residues as reactive sites into Fos and fusion
+
-
of thiol-reactive cross-linkers to them results in intramolecular
+
-
cross-linking of the Fos protein. By a photo-switch between cis and
+
-
trans conformations these cross-linkers can change their end to end
+
-
distance. Thus isomerization can be used to promote helix folding or
+
-
unfolding of Fos.<br />
+
</p>
</p>
-
<div class="thumb tnone">
+
 
-
<div class="thumbinner" style="width: 366px;">
+
 
-
<div class="thumbcaption">
+
 
-
<div class="magnify"><a
+
 
-
href="http://www.molbiotech.uni-freiburg.de/iGEM/wiki2009/index.php/Image:Freiburg09_Fos_foka_foki_interact.JPG"
+
 
-
class="internal" title="Enlarge"><br />
+
 
-
</a></div>
+
 
 +
 
 +
 
<br />
<br />
-
<table style="text-align: left; width: 900px;" border="0"
 
-
cellpadding="2" cellspacing="2">
 
-
  <tbody>
 
-
    <tr>
 
-
      <td><a
 
-
href="http://www.molbiotech.uni-freiburg.de/iGEM/wiki2009/index.php/Image:Freiburg09_Fos_foka_foki_interact.JPG"
 
-
class="image"
 
-
title="the His_Fos-Splitli-Fok_a, FosW and His-FluA-Splitli-Fok_i cut the DNA"><img
 
-
alt="the His_Fos-Splitli-Fok_a, FosW and His-FluA-Splitli-Fok_i cut the DNA"
 
-
src="http://www.molbiotech.uni-freiburg.de/iGEM/wiki2009/images/4/42/Freiburg09_Fos_foka_foki_interact.JPG"
 
-
class="thumbimage" border="0" height="186"
 
-
width="364" /></a></td>
 
-
    </tr>
 
-
    <tr>
 
-
      <td>the His_Fos-Splitli-Fok_a, FosW and
 
-
His-FluA-Splitli-Fok_i cut the DNA</td>
 
-
    </tr>
 
-
  </tbody>
 
-
</table>
 
</div>
</div>
</div>
</div>

Latest revision as of 10:28, 17 November 2009

FREiGEM

Figure1: Human c-Fos:c-Jun:DNA complexes

Introduction
We also thought of an alternative way of binding of the heterodimeric Fok to the DNA avoiding the necessity of labeled oligos and their binding proteins. Therefore, we used the DNA binding domain of a transcription factor as a new adapter between the Fok construts and the DNA. We focused on the binding domain of the Activator Protein-1 (AP-1), a crucial transcription factor implicated in numerous cancers.

AP-1, which belongs to the bZIP type of transcription factors, binds DNA as a dimer like many eukaryotic transcription factor. Protein-protein interaction is mediated via a leucin zipper (ZIP), and with their basic region (b) they bind DNA. Nine homologues of the AP-1 leucine zipper region have been characterized, among them natural occurring c-Fos, c-Jun and library-designed winning peptides FosW and JunW. Each of the homologues is able to form heterodimers, some also form homodimers.

There are two classes of core DNA sequences, the sequences TRE (TGACTCA) and CRE (TGACGTCA), which are recognized by the different AP-1 factors.

For our needs, we chose the natural bZIP sequence of Fos and Jun as well as the library-selected FosW sequence. By fusion of Fos with Splitli-Fok_a, the construct Fos-Splitli-Fok_a was obtained. Control of DNA cleavage occurs on two levels: (i) using the bZIP sequence of Jun as adapter, DNA binding can be induced, and (ii) adding Fok_i will render Fok activ leading to DNA cleavage.

For further control of DNA cleavage activity, a light-switchable peptide, FosW, can be used to interfere with Fos/Jun DNA binding. For this, two Cys residues were introdued in FosW presenting reactive sites for thiol-reactive linkers. Thus an azobenzene derivative as intramolecular cross-linker can be coupled to the cysteines. Depending on the wavelenth of light used the linker undergoes cis/trans isomerization promoting the folding or unfolding of the FosW helix (see Figure 3).

Western Blot: His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls
Figure 3: light-switchable FosW interrupts binding of Jun:Fos



Using this light-switchable FosW derivative, FosW binds in its light-activated form to Jun and Fos, displacing them from the DNA and thus disrupts Fok-mediated DNA cleavage. Switching FosW back to its inactivated form, Jun and Fos are released, can rebind to the DNA and Fok-mediated cleavage should occur again.

The assay with the photoswitchable FosWinner interrupting the binding of the heterodimeric complex of Fos and Jun was already done by the laboratory of Katja Arndt in Freiburg and underlines the feasibility of the method.

Methods


Figure 2: Above: Fos and Jun dimerize, bind the DNA and lead Fok construct to DNA, Below: activated FosW prevents DNA binding
We ordered the sequences for the basic leucine zipper (bZip) domains of c-Fos linked to a His-tag for the purification. The cloning of the construct His_Fos and Splitli-Foka into the pEX expression vector was done by a triple ligation. The first insert, His_Fos was cut out by XbaI and AgeI, the second insert, Splitli-Fok_a by NgoMIV and PstI, the vector was cut open with XbaI and PstI. Now the whole construct His_Fos-Splitli-Fok_a can be expressed as a soluble protein in E. coli. For further or alternative purification in addition to His-tag/Ni-NTA purification, we used a GST-FosW fusion protein from the stock of the laboratory of Katja Arndt, where GST (glutathione S-transferase) can bind to GSH (glutathion) sepharose. GST-FosW was expressed in E. coli and bound to the GSH-Sepharose column. This can serve as affinity column for the purification of His_Fos-Splitli-Fok_a. The already expressed His-FluA-Splitli-Fok_i is serving as an expressed Fok_i protein, but any other Fok_i should work as well. For the recombinant expression, RV308 served as host for His_Fos-Splitli-Fok_a and BL21de3 for His-FluA-Splitli-Fok_i. For induction of expression, we used 0.6 mM isopropyl-beta-D-thiogalactopyranoside (IPTG). His-FluA-Splitli-Fok_i was purified to homogeneity via a Ni-NTA column, whereas His_Fos-Splitli-Fok_a will be purified by an affinity chromatography using a glutathion column with bound GST-FosW. For analysis of the cleavage activity of the Fos-Splitli_Fok_a construct interacting with Jun and His-FluA-Splitli-Fok_i we will use reporter plasmids containing the target recognition sequences of Fos and Jun as substrates.

Results and Discussion
The cloning of the construct His_Fos and Splitli-Foka into the pEX expression vector was done by a triple ligation. The first insert, His_Fos was cut out by XbaI and AgeI, the second insert, Splitli-Fok_a by NgoMIV and PstI, the vector was cut open with XbaI and PstI. The cloning was successful, and the concentration of the plasmid and the sequencing of clones were good.

Sample ID User ID Date Time ng/ul A260 A280 260/280 260/230 Constant Cursor Pos. Cursor abs. 340 raw
pExFosSplitFokaK1 FreiGEM 14.10.2009 19:36 76.19 1.524 0.758 2.01 2.16 50.00 230 0.705 -0.009
pExFosSplitFokaK2 FreiGEM 14.10.2009 19:37 50.13 1.003 0.491 2.04 2.21 50.00 230 0.453 0.078

The recombinant expression of the single parts His_Fos-Splitli-Fok_a, GST-FosW and His-FluA-Splitli-Fok_i was performed. His-FluA-Splitli-Fok_i was successfully purified via a Ni-NTA column. The western blot with an anti-His antibody shows a band of the expected size of 467 kDa in the pooled elution fraction. GST-FosW was expressed and coupled to the GSH-sepharose column for the purification of His_Fos-Splitli-Fok_a, which will be the next step followed by the in vitro cleavage assays.

Western Blot: His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls
Figure 5: Western Blot (anti-His antibody): His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls for His-tag detection.





Retrieved from "http://2009.igem.org/Team:Freiburg_bioware/Project/FOS"